Is Rockwell Medical Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: RMTI) stock is to Buy RMTI stock.
Out of 1 analyst, 0 (0%) are recommending RMTI as a Strong Buy, 1 (100%) are recommending RMTI as a Buy, 0 (0%) are recommending RMTI as a Hold, 0 (0%) are recommending RMTI as a Sell, and 0 (0%) are recommending RMTI as a Strong Sell.
What is RMTI's earnings growth forecast for 2023-2023?
(NASDAQ: RMTI) Rockwell Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Rockwell Medical's earnings in 2023 is -$25,260,000.
In 2023, RMTI is forecast to generate -$26,406,168 in earnings, with the lowest earnings forecast at -$26,406,168 and the highest earnings forecast at -$26,406,168.
What is RMTI's forecast return on equity (ROE) for 2023-2023?
(NASDAQ: RMTI) forecast ROE is -163.65%, which is considered weak.
What is RMTI's Price Target?
According to 1 Wall Street analyst that have issued a 1 year RMTI price target, the average RMTI price target is $8.00, with the highest RMTI stock price forecast at $8.00 and the lowest RMTI stock price forecast at $8.00.
The Wall Street analyst predicted that Rockwell Medical's share price could reach $8.00 by Aug 30, 2023. The average Rockwell Medical stock price prediction forecasts a potential upside of 318.85% from the current RMTI share price of $1.91.
What is RMTI's Earnings Per Share (EPS) forecast for 2023-2023?
(NASDAQ: RMTI) Rockwell Medical's current Earnings Per Share (EPS) is -$2.79. In 2023, RMTI's EPS is forecast to hit -$2.27 (min: -$2.27, max: -$2.27).
What is RMTI's forecast return on assets (ROA) for 2023-2023?
(NASDAQ: RMTI) forecast ROA is -48.73%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 9.81%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.